| 注册
首页|期刊导航|中外医学研究|沙库巴曲缬沙坦钠联合卡维地洛在老年慢性心力衰竭患者中的应用效果

沙库巴曲缬沙坦钠联合卡维地洛在老年慢性心力衰竭患者中的应用效果

刘洪波

中外医学研究2024,Vol.22Issue(23):27-30,4.
中外医学研究2024,Vol.22Issue(23):27-30,4.DOI:10.14033/j.cnki.cfmr.2024.23.007

沙库巴曲缬沙坦钠联合卡维地洛在老年慢性心力衰竭患者中的应用效果

Application Effect of Sacubitril Valsartan Sodium Combined with Carvedilol in Elderly Patients with Chronic Heart Failure

刘洪波1

作者信息

  • 1. 重庆市万盛经济技术开发区中医院 重庆 400800
  • 折叠

摘要

Abstract

Objective:To explore the application effect of Sacubitril Valsartan Sodium combined with Carvedilol in elderly patients with chronic heart failure(CHF).Method:A total of 80 elderly patients with CHF who admitted to Chongqing Wansheng Economic and Technological Development Zone Traditional Chinese Medicine Hospital from August 2022 to August 2023 were selected as the research objects,they were divided into the control group(n=40)and the observation group(n=40)according to the random number table method.The control group was treated with Carvedilol Tablets,while the observation group was treated with Sacubitril Valsartan Sodium Tablets on the basis of the control group.The clinical efficacy,serological indexes[N-terminal B-type pronatriuretic peptide(NT-proBNP),growth differentiation factor-15(GDF-15),soluble intercellular adhesion rnolecule-1(sICAM-1)],vital signs[heart rate(HR),diastolic blood pressure(DBP),systolic blood pressure(SBP)],adverse reactions and quality of life were compared between two groups.Result:The total effective rate of the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).Before treatment,there were no significant differences in the serological indexes,vital signs and Minnesota living with heart failure questionnaire(MLHFQ)scores between two groups(P>0.05);after treatment,the levels of GDF-15,NT-proBNP,sICAM-1,SBP,DBP,HR and MLHFQ scores in two groups were lower than those before treatment,and those in the observation group were lower than the control group,the differences were statistically significant(P<0.05).There was no significant difference in the incidence of adverse reactions between two groups(P>0.05).Conclusion:Sacubitril Valsartan Sodium combined with Carvedilol is effective in the treatment of elderly patients with CHF,which can effectively regulate serological indicators and vital signs,with high safety and quality of life.

关键词

慢性心力衰竭/老年/沙库巴曲缬沙坦钠/心功能

Key words

Chronic heart failure/Elderly/Sacubitril Valsartan Sodium/Cardiac function

引用本文复制引用

刘洪波..沙库巴曲缬沙坦钠联合卡维地洛在老年慢性心力衰竭患者中的应用效果[J].中外医学研究,2024,22(23):27-30,4.

中外医学研究

1674-6805

访问量0
|
下载量0
段落导航相关论文